Related Experiment Video
Updated: Sep 2, 2025

Left Atrial Stenosis Induced Pulmonary Venous Arterialization and Group 2 Pulmonary Hypertension in Rat
Published on: November 18, 2018
Symptomatic and severe pulmonary hypertension due to hyperthyroidism
Tadashi Itagaki1, Takashi Miura2,3, Toshio Kasai2
1Department of Cardiology, Nagano Municipal Hospital, Tomitake, Nagano, Japan itagaki@shinshu-u.ac.jp.
Hyperthyroidism can cause severe pulmonary hypertension (PH), even in symptomatic cases. Early diagnosis and treatment of hyperthyroidism are crucial for improving PH outcomes.
Area of Science:
- Cardiology
- Endocrinology
- Pulmonary Medicine
Background:
- Hyperthyroidism is a known cause of secondary pulmonary hypertension (PH).
- Previous studies suggest PH associated with hyperthyroidism is often asymptomatic and mild.
Observation:
- A woman in her 30s presented with symptomatic, severe PH, including dyspnea and edema.
- Echocardiography revealed severe PH with an estimated pulmonary arterial systolic pressure (ePASP) of 62 mm Hg.
Findings:
- Diagnostic work-up confirmed severe PH directly caused by hyperthyroidism.
- Following treatment for hyperthyroidism, thyroid function normalized, and ePASP decreased to 30 mm Hg.
Implications:
- This case highlights that hyperthyroidism can lead to severe, symptomatic PH.
- Emphasizes the importance of considering and screening for hyperthyroidism in PH patients.
- Early diagnosis and treatment of hyperthyroidism are vital for managing and improving PH.
More Related Videos
07:29The Left Pneumonectomy Combined with Monocrotaline or Sugen as a Model of Pulmonary Hypertension in Rats
Published on: March 8, 2019
07:41Induction and Phenotyping of Acute Right Heart Failure in a Large Animal Model of Chronic Thromboembolic Pulmonary Hypertension
Published on: March 17, 2022
Related Concept Videos
Pulmonary Hypertension: Classification and Pathogenesis
There are various classifications for PH, each relating to different underlying causes and also...
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
Mitral Stenosis II: Clinical features and Diagnostic Tests
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Mitral Regurgitation I: Introduction